Figure 1.
Schematic schedule of the study design with animals allocated into major groups according to the duration of the treatment free interval after the last injection of 1,2-dimethylhydrazine. Mice were then allocated to subgroups with different durations of treatment, with daily injections of 25 μg native glucagon-like peptide 2 (GLP-2), 25 μg Gly2-GLP-2, or phosphate buffered saline (controls).